Medical Equipment

Global Immunohistochemistry (IHC) Market Report 2026–2035 Highlighting Expansion Outlook and Forecast Opportunities

March 12, 2026March 18, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Immunohistochemistry (IHC) Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The immunohistochemistry (ihc) market has seen substantial expansion in recent years. Its valuation is anticipated to climb from $2.76 billion in 2025 to $3.05 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.3%. This historical growth can be attributed to factors such as the increasing application of ihc in cancer diagnostics, the expansion of hospital pathology laboratories, greater availability of monoclonal antibodies, a rise in the adoption of tissue-based diagnostics, and growing clinical research activities.

The immunohistochemistry (ihc) market is projected to experience substantial expansion over the coming years. Its valuation is anticipated to reach $4.47 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.1%. This projected increase throughout the forecast period stems from factors such as a heightened need for precision oncology diagnostics, the growing embrace of AI-powered pathology analysis, the broadening scope of biomarker-driven drug development, the escalating application of multiplex tissue profiling, and greater capital expenditure in sophisticated pathology infrastructure. Key developments expected during this period include the wider uptake of automated ihc staining systems, an increase in the utilization of multiplex ihc techniques, the deeper incorporation of digital pathology platforms, the expansion of companion diagnostic applications, and a reinforced emphasis on high-specificity antibodies.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9267&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Immunohistochemistry (IHC) Market?

The increasing need for personalized medicines is projected to boost the expansion of the immunohistochemistry (IHC) market in the coming years. Personalized medicine represents a healthcare strategy focused on customizing medical choices, procedures, treatments, and products for each patient, considering their distinct genetic makeup, environmental factors, and lifestyle. Immunohistochemistry (IHC) is crucial in personalized medicine, as it helps identify specific protein markers essential for precise tumor classification and diagnosis. For example, in February 2024, data from the Personalized Medicine Coalition, a US-based non-profit research organization, indicated that personalized medicines constituted more than one-third of new approvals by the US Food and Drug Administration in 2023. Additionally, in the same year, the FDA granted approval for 16 new personalized treatments aimed at rare-disease patients, marking an increase from 6 in 2022. Consequently, the rising demand for personalized medicines is stimulating the growth of the immunohistochemistry (IHC) market.

What Major Segment Divisions Exist Within The Immunohistochemistry (IHC) Market?

The immunohistochemistry (ihc) market covered in this report is segmented –

1) By Product: Antibodies, Equipment, Reagents, Kits

2) By Applications: Diagnostics, Drug Testing, Other Applications

3) By End-Users: Hospitals And Diagnostic Laboratories, Research Institutes, Other End-Users

Subsegments:

1) By Antibodies: Primary Antibodies, Secondary Antibodies, Conjugated Antibodies

2) By Equipment: IHC Staining Systems, Slide Scanners, Microscopes

3) By Reagents: Detection Reagents, Blocking Reagents, Mounting Media

4) By Kits: Pre-prepared IHC Kits, Multiplex IHC Kits, Specialty Kits

How Are Trends Shaping The Direction Of The Immunohistochemistry (IHC) Market?

Leading companies in the immunohistochemistry (IHC) market are prioritizing improvements in diagnostic accuracy through innovative technologies and high-quality reagents, aiming to boost the effectiveness of tissue analysis across various clinical and research contexts. The Neoflex multiomics mass spectrometry imaging (MSI) system stands as an advanced imaging platform crafted for precise tissue analysis, enabling researchers to transition from initial discoveries to clinical applications utilizing high-resolution mass spectrometry techniques, particularly for the spatial mapping of biomolecules within tissues. For instance, in June 2024, Bruker Corporation, a US-based entity focused on developing and manufacturing scientific instruments alongside analytical and diagnostic solutions, unveiled its matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF/TOF) Neoflex Imaging Profiler for mass spectrometry-based tissue imaging. The Neoflex multiomics mass spectrometry imaging (MSI) system is engineered to facilitate the advancement from discovery imaging to clinical tissue research, incorporating Bruker’s 10-kHz smartbeam 3D laser, enhanced imaging detectors, and supporting OME-TIFF file output through SCiLS Scope software.

Which Companies Are Leading Innovation In The Immunohistochemistry (IHC) Market?

Major companies operating in the immunohistochemistry (ihc) market are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, Merck Group, Danaher Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB Inc., Agilent Technologies Inc., Abcam plc, Takara Bio Inc., Biocare Medical LLC, Bio-Genex Laboratories, Diagnostic BioSystems Inc., PHC Holdings Corporation, Leica Biosystems, Vector Laboratories, Ionpath Inc., Reveal Biosciences, Akrivis Technologies Private Limited, LifeSpan BioSciences Inc., Enzo Life Sciences Inc., Epitomics Inc., GenScript Biotech

Read the full immunohistochemistry (ihc) market report here:

https://www.thebusinessresearchcompany.com/report/immunohistochemistry-ihc-global-market-report

What Are The Leading Geographic Regions In The Immunohistochemistry (IHC) Market?

North America was the largest region in the immunohistochemistry (IHC) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the immunohistochemistry (IHC) market report during the forecast period. The regions covered in the immunohistochemistry (ihc) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Immunohistochemistry (IHC) Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9267&type=smp

Browse Through More Reports Similar to the Global Immunohistochemistry (IHC) Market 2026, By The Business Research Company

Immunohematology Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Immunoassay Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

Immunotoxin Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunotoxin-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795